CFFT Activities Transferred to the CF Foundation

This week, Congress approved a budget resolution that will allow lawmakers to make certain changes to the Affordable Care Act and Medicaid.

| 1 min read

Over the course of 2018, we will be transferring the activities of Cystic Fibrosis Foundation Therapeutics Inc. (CFFT) to the CF Foundation. As our nonprofit drug discovery and development affiliate, CFFT was already controlled by the Foundation. Therefore, this transfer merely reflects a shift in the formal organizational structure to reduce potential confusion by the CF community and simplify administration, enabling us to operate optimally to achieve our mission.

Learn about the cutting-edge research conducted at the Cystic Fibrosis Foundation Therapeutics Lab, dedicated to advancing new therapies for everyone with cystic fibrosis, as well as the extensive range of research that the Foundation supports.

Share this article
Topics
Our Research Approach
Recent news
CF Foundation Awards Advance Improvements in CF Newborn Screening
News | 4 min read
Cystic Fibrosis Foundation Awards 2023 Impact Grants
News | 5 min read
Adult with CF Provides Testimony at Congressional Hearing on the Impact of Antimicrobial Resistance 
News | 3 min read
You might also be interested in...
Stay up to date with The Foundation

Sign up for our newsletter to get all of the latest news from The Foundation right in your inbox.

Subscribe